Bioprocessing White Papers

1. Why Smarter Handling Can Save Your Production Line From Inefficiencies 11/3/2026

   Line performance in packaging is often decided between machines, not within them. Treating handling as a discipline rather than an afterthought changes how flow, protection, and growth are planned.

2. Biomanufacturing Readiness: A Validation Model For Multiproduct Facilities 10/26/2026

   Optimize your validation strategy to meet evolving regulatory demands and product complexities with a scalable, efficient framework that accelerates facility readiness and ensures consistent quality.

3. High-Throughput Binding Affinity Assessment Using Octet® HTX 10/22/2026

   Binding affinity screening of clones directly from crude supernatant, without purification, changes what can be assessed early, and a tiered workflow pairs broad throughput with deeper analytical characterization.

4. From Laboratory To Launchpad: Japan's Cell And Gene Therapy Ecosystem Hits Its Stride 10/21/2026

   Japan is emerging as a credible cell and gene therapy hub as regulation, manufacturing, and capital advance, despite gaps in funding, talent, risk culture, and language.

5. Eliminate Variability, Accelerate Results: Value Of Ready-To-Use Reagents 10/15/2026

   Pre-made solutions reduce operator variability, save bench time, and lower contamination risk by eliminating reagent preparation and reducing handling.

6. Is Your Water Undermining Your Results? 10/15/2026

   Water is often chosen by availability rather than application. Defining it as a controlled process parameter targets a variability source that routinely escapes root cause analysis.

7. Why Reagent Quality Defines Research Success 10/15/2026

   Water grade, buffer preparation, and packaging each shape whether sensitive assays hold up. Reagent selection hinges on matching purity to application sensitivity, regulatory standards, and tolerance for contamination risk.

8. Single-use Mixing Systems For Protein Products: Dissolution And Mechanical Stress 10/14/2026

   Mixer design and fill volume shape both how well a solution homogenizes and how much mechanical stress a protein experiences. Impeller configurations are compared against a conventional stirrer.

9. Accelerating Complex Generic Drug Development Through Advanced Deformulation 10/13/2026

   With FDA no longer identifying Q1/Q2 differences, applicants bear the diagnostic burden. Reverse engineering now directly affects development speed, cost, and approval.

10. Endotoxin Control In The Process Development Lab 10/13/2026

    Endotoxin control in E. coli fermentation depends on effective removal, purification, and NaOH cleaning strategies, with risks evolving as manufacturing progresses.